CD79A and COVID-19: Within the identified epitopes, the pre-COVID-19 samples had an IgG antibody response higher than the median of infected samples in 14% of the epitopes (n=3) and an IgA antibody response higher than the median of infected samples in 29% (n=6) of the epitopes.